Economic aspects of treating seizure clusters

  title={Economic aspects of treating seizure clusters},
  author={Edward Faught},
  pages={S45 - S54}
  • E. Faught
  • Published 23 August 2022
  • Medicine, Economics
  • Epilepsia
Seizure clusters may initiate a chain of events that have economic as well as clinical consequences. The potential economic consequences of seizure clusters must be weighed against the cost of medication to attenuate them. This is true both for individual patients and for society. Data needed for economic analyses include the chance that a cluster will progress to an adverse outcome, such as a need for emergency care, the costs of such an outcome, the cost of a rescue medication (RM), and the… 



Seizure clusters: characteristics and treatment.

  • S. Haut
  • Medicine
    Current opinion in neurology
  • 2015
Progress towards the development of nonintravenous routes of benzodiazepines has the potential to improve care in this area and greater focus on clarifying of definition and clinical implications is required.

Rescue therapies for seizure emergencies: New modes of administration

The objective of this narrative review is to describe the anatomical, physiologic, and drug physicochemical properties that need to be considered when developing therapies for seizure emergencies and products currently in development.

Cost of epilepsy-related health care encounters in the United States.

This is the first study to report health plan-paid cost per epilepsy-related health care encounter and can serve as a basis for more granular cost-benefit analyses of not only chronic but also acute treatments of epilepsy.

A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe

Despite differences in current therapy, treatment patterns and healthcare costs in all countries assessed, BUCCOLAM was shown to be cost saving and offered increased health-related benefits for patients in the treatment of PACS compared with the current local standard of care.

Economic and social cost of epilepsy in Poland: 5-year analysis

The most current direct and indirect costs of epilepsy in Poland from the social perspective for the years 2014-2018 are determined to analyze the changes of expenditures over time, indicate trends and to determine key cost-drivers.